FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example CodeSystem/regulated-authorization-basis (JSON)

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: Informative

Raw JSON (canonical form + also see JSON Format Specification)

Definition for Code SystemRegulatedAuthorizationBasis

{
  "resourceType" : "CodeSystem",
  "id" : "regulated-authorization-basis",
  "meta" : {
    "lastUpdated" : "2024-06-18T05:39:48.620+11:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>http://hl7.org/fhir/regulated-authorization-basis</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">Full<a name=\"regulated-authorization-basis-Full\"> </a></td><td>Full application</td></tr><tr><td style=\"white-space:nowrap\">NewSubstance<a name=\"regulated-authorization-basis-NewSubstance\"> </a></td><td>New active substance</td></tr><tr><td style=\"white-space:nowrap\">KnownSubstance<a name=\"regulated-authorization-basis-KnownSubstance\"> </a></td><td>Known active substance</td></tr><tr><td style=\"white-space:nowrap\">SimilarBiological<a name=\"regulated-authorization-basis-SimilarBiological\"> </a></td><td>Similar biological application</td></tr><tr><td style=\"white-space:nowrap\">Well-establishedUse<a name=\"regulated-authorization-basis-Well-establishedUse\"> </a></td><td>Well-established use application</td></tr><tr><td style=\"white-space:nowrap\">TraditionalUse<a name=\"regulated-authorization-basis-TraditionalUse\"> </a></td><td>Traditional use registration for herbal medicinal product application</td></tr><tr><td style=\"white-space:nowrap\">Bibliographical<a name=\"regulated-authorization-basis-Bibliographical\"> </a></td><td>Bibliographical application (stand-alone)</td></tr><tr><td style=\"white-space:nowrap\">KnownHumanBlood<a name=\"regulated-authorization-basis-KnownHumanBlood\"> </a></td><td>Known human blood/plasma derived ancillary medicinal substance</td></tr><tr><td style=\"white-space:nowrap\">TemporaryUse<a name=\"regulated-authorization-basis-TemporaryUse\"> </a></td><td>Authorizations for temporary use</td></tr><tr><td style=\"white-space:nowrap\">ParallelTrade<a name=\"regulated-authorization-basis-ParallelTrade\"> </a></td><td>Parallel traded products</td></tr></table></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode" : "brr"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
    "valueCode" : "trial-use"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
    "valueInteger" : 1
  }],
  "url" : "http://hl7.org/fhir/regulated-authorization-basis",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.4.1907"
  }],
  "version" : "6.0.0-cibuild",
  "name" : "RegulatedAuthorizationBasis",
  "title" : "Regulated Authorization Basis",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-01-05T10:01:24+11:00",
  "publisher" : "HL7 (FHIR Project)",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "http://hl7.org/fhir"
    },
    {
      "system" : "email",
      "value" : "fhir@lists.hl7.org"
    }]
  }],
  "description" : "RegulatedAuthorizationBasis",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "001",
      "display" : "World"
    }]
  }],
  "caseSensitive" : true,
  "valueSet" : "http://hl7.org/fhir/ValueSet/regulated-authorization-basis",
  "content" : "complete",
  "concept" : [{
    "code" : "Full",
    "display" : "Full application"
  },
  {
    "code" : "NewSubstance",
    "display" : "New active substance"
  },
  {
    "code" : "KnownSubstance",
    "display" : "Known active substance"
  },
  {
    "code" : "SimilarBiological",
    "display" : "Similar biological application"
  },
  {
    "code" : "Well-establishedUse",
    "display" : "Well-established use application"
  },
  {
    "code" : "TraditionalUse",
    "display" : "Traditional use registration for herbal medicinal product application"
  },
  {
    "code" : "Bibliographical",
    "display" : "Bibliographical application (stand-alone)"
  },
  {
    "code" : "KnownHumanBlood",
    "display" : "Known human blood/plasma derived ancillary medicinal substance"
  },
  {
    "code" : "TemporaryUse",
    "display" : "Authorizations for temporary use"
  },
  {
    "code" : "ParallelTrade",
    "display" : "Parallel traded products"
  }]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.